Diagnostic value of circulating genetically abnormal cells to support computed tomography for benign and malignant pulmonary nodules

Diagnostic value of circulating genetically abnormal cells to support computed tomography for benign and malignant pulmonary nodules

Background: The accuracy of CT and tumour markers in screening lung cancer needs to be improved. Computer-aided diagnosis has been reported to effectively improve the diagnostic accuracy of imaging data, and recent studies have shown that circulating genetically abnormal cell (CAC) has the potential...

Full description

Bibliographic Details
Main Authors: Chen, H. (Author), Li, H. (Author), Liu, H. (Author), Ni, R. (Author), Wu, Y. (Author), Yang, H. (Author), Yu, Y. (Author), Zhang, G. (Author), Zhang, Y. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
antigen CYFRA21.1
Antigens, Neoplasm
artificial intelligence
Artificial Intelligence
Biomarkers, Tumor
Circulating genetically abnormal cells (CAC)
Computed tomography (CT)
cytokeratin 19
diagnostic imaging
early cancer diagnosis
Early Detection of Cancer
Early diagnosis
genetics
human
Humans
Keratin-19
Lung cancer
Lung Neoplasms
lung nodule
lung tumor
multiple pulmonary nodules
Multiple Pulmonary Nodules
procedures
Pulmonary nodules
Solitary Pulmonary Nodule
Tomography, X-Ray Computed
tumor antigen
tumor marker
x-ray computed tomography
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items